News | August 07, 2021
Bafna Pharma posts Q1FY 21-22 net at Rs. 2.08 Cr
This robust growth has come despite the raging pandemic for most part of the quarter
This robust growth has come despite the raging pandemic for most part of the quarter
In the agreement, Marcor, an Azelis Americas company, will distribute the SPI Pharma product lines in the United States, and Azelis Canada Pharma Division will be responsible for the Canadian marketplace
He will be responsible for the company's overall strategy and provide the necessary direction and dynamic leadership to R&D, manufacturing, business development, and commercial operations
He will be stationed at the company HQ in Bengaluru, India
CDSCO to fast-track trials and approval for COVID19 vaccine
Innovative solutions and a deep understanding of the market makes this a unique combination
It had an estimated market size of US $ 32 million as of June 2021
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
Arch Pharma Labs has filed the application
Robust demand for the product across the Middle East, Africa and Latin America
Subscribe To Our Newsletter & Stay Updated
